Skip to main content

Table 2 Liver function tests in patients with renal failure at start and end of intravenous voriconazole therapy

From: Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy

  ASAT (IU/l)a γ-GT (IU/l)b Total bilirubin (mg/dl)c
  start end start end start end
patient no. 1 104 24 119 264 2.32 1.39
patient no. 2 100 26 93 71 0.83 0.32
patient no. 3 54 25 288 443 4.93 7.27
patient no. 4 30 22 238 216 3.29 1.34
  1. anorm < 37 IU/l, bnorm 10–66 IU/L, cnorm 0.1–1.2 mg/dl